In an opinion essay for STAT, cardiac electrophysiologist Subramaniam C. Krishnan recounts how studying preserved human hearts at the Jesse E. Edwards Registry in Minnesota led him to discover a previously undescribed structure: a small pouch, 8–11 mm deep, opening into the left atrium. First published in 2010, the left atrial septal pouch (LASP) is now known to exist in roughly one in three adult hearts, yet it went unrecognized for centuries because anatomy was assumed to be a completed science.
Krishnan notes that the LASP resembles the left atrial appendage—a blind-ended pocket where blood can stagnate and clot—but unlike the appendage, it can do so even in normal heart rhythm. Observational studies over the past 16 years have suggested a link to unexplained, cryptogenic strokes, but they could only establish association. That changed with a recent randomized trial from Fuwai Hospital in Beijing, which showed that mechanically excluding the pouch with a septal occluder device was associated with a marked reduction in recurrent ischemic brain lesions compared with medical therapy alone. Krishnan cautions that the trial is not definitive, but it is the first demonstration that directly treating the structure might alter outcomes.
The author argues that the LASP's trajectory mirrors that of the patent foramen ovale (PFO), which took decades of research before closure became accepted therapy for selected stroke patients. He also draws a broader lesson: discovery often depends less on advanced technology than on questioning assumptions about where to stop looking. His subsequent work on an implant-free PFO closure strategy grew directly from studying the pouch, illustrating how anatomical observation can generate therapeutic hypotheses. While modern medicine invests heavily in genomics and AI, Krishnan urges that anatomy still has secrets to reveal—and that careful observation remains a reliable engine of discovery. (This article is based solely on the opinion piece by Krishnan; no other sources were provided.)